迪哲医药-U
(688192)
| 流通市值：296.77亿 | | | 总市值：332.75亿 |
| 流通股本：4.10亿 | | | 总股本：4.59亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,244,565,866.2 | 252,506,571.33 | 250,164,742.63 | 130,831,963.06 |
| 交易性金融资产 | 1,006,143,043.86 | 646,255,080.82 | 589,829,954.53 | 677,467,023.71 |
| 应收票据及应收账款 | 82,138,364.53 | 45,433,879.93 | 27,494,978.71 | 80,917,263.2 |
| 应收账款 | 82,138,364.53 | 45,433,879.93 | 27,494,978.71 | 80,917,263.2 |
| 预付款项 | 26,668,186.35 | 24,133,013.17 | 61,344,011.68 | 31,984,515.32 |
| 其他应收款合计 | 3,341,912.44 | 3,089,506.04 | 3,357,740.39 | 3,634,102.13 |
| 存货 | 40,547,178.15 | 37,543,431.25 | 44,114,737.09 | 34,626,457.01 |
| 其他流动资产 | 1,522,475.25 | 11,745,369.83 | 22,666,638.75 | 17,461,163.22 |
| 流动资产合计 | 2,404,927,026.78 | 1,020,706,852.37 | 998,972,803.78 | 976,922,487.65 |
| 非流动资产: | | | | |
| 固定资产 | 17,973,029.66 | 19,740,053.03 | 20,361,429.9 | 20,660,331.68 |
| 在建工程 | 283,305,976.64 | 212,865,945.27 | 169,723,895.95 | 105,753,565.7 |
| 使用权资产 | 41,535,501.37 | 47,681,254.09 | 53,827,006.81 | 62,195,451.44 |
| 无形资产 | 412,980,312.94 | 421,375,933.73 | 429,848,566.48 | 437,860,297.35 |
| 长期待摊费用 | 5,055,686.64 | 6,791,229.59 | 8,624,083.47 | 10,686,598.19 |
| 其他非流动资产 | 52,683,051.28 | 75,678,189.68 | 37,380,097.66 | 28,430,325.57 |
| 非流动资产合计 | 813,533,558.53 | 784,132,605.39 | 719,765,080.27 | 665,586,569.93 |
| 资产总计 | 3,218,460,585.31 | 1,804,839,457.76 | 1,718,737,884.05 | 1,642,509,057.58 |
| 流动负债: | | | | |
| 短期借款 | 359,939,606.82 | 446,719,984.66 | 373,826,883.84 | 235,184,441.1 |
| 应付票据及应付账款 | 164,657,570.66 | 142,718,536.08 | 139,086,612.53 | 127,226,939.21 |
| 应付账款 | 164,657,570.66 | 142,718,536.08 | 139,086,612.53 | 127,226,939.21 |
| 合同负债 | 7,678,449.47 | 4,675,455.53 | 2,930,065.47 | 2,665,900 |
| 应付职工薪酬 | 87,668,400.72 | 50,073,741.56 | 69,830,119.46 | 75,862,206.9 |
| 应交税费 | 8,846,372.64 | 15,116,405.59 | 10,233,481.36 | 7,429,488.15 |
| 其他应付款合计 | 128,755,545.42 | 124,094,262.22 | 124,369,006.05 | 73,926,693.07 |
| 一年内到期的非流动负债 | 130,654,318.03 | 109,864,792.11 | 64,808,334.11 | 44,605,234.63 |
| 流动负债合计 | 888,200,263.76 | 893,263,177.75 | 785,084,502.82 | 566,900,903.06 |
| 非流动负债: | | | | |
| 长期借款 | 660,814,178.14 | 842,159,289.3 | 683,761,593.76 | 584,395,297.38 |
| 租赁负债 | 26,542,814.74 | 31,398,319.07 | 34,991,563.78 | 39,763,903.1 |
| 递延收益 | 14,125,803.33 | 14,484,564.69 | 14,843,326.06 | 14,202,087.44 |
| 非流动负债合计 | 701,482,796.21 | 888,042,173.06 | 733,596,483.6 | 638,361,287.92 |
| 负债合计 | 1,589,683,059.97 | 1,781,305,350.81 | 1,518,680,986.42 | 1,205,262,190.98 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 459,412,894 | 417,648,086 | 417,648,086 | 415,653,120 |
| 资本公积 | 4,901,627,087.15 | 3,152,846,806.53 | 3,135,628,867.3 | 3,084,806,061.63 |
| 未分配利润 | -3,736,881,278.44 | -3,552,034,501.85 | -3,359,521,152.9 | -3,072,025,396.91 |
| 归属于母公司股东权益合计 | 1,624,158,702.71 | 18,460,390.68 | 193,755,800.4 | 428,433,784.72 |
| 少数股东权益 | 4,618,822.63 | 5,073,716.27 | 6,301,097.23 | 8,813,081.88 |
| 股东权益合计 | 1,628,777,525.34 | 23,534,106.95 | 200,056,897.63 | 437,246,866.6 |
| 负债和股东权益合计 | 3,218,460,585.31 | 1,804,839,457.76 | 1,718,737,884.05 | 1,642,509,057.58 |
| 公告日期 | 2025-08-23 | 2025-04-30 | 2025-04-30 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |